The structural complexity of the human BORIS gene in gametogenesis and cancer.
about
A cell cycle role for the epigenetic factor CTCF-L/BORISWidespread expression of BORIS/CTCFL in normal and cancer cellsDifferent Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem CellsDose-dependent activation of putative oncogene SBSN by BORISHypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.High expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells.Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2'-deoxycytidine-triggered invasivenessDifferential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein.Cohesin complexes with a potential to link mammalian meiosis to cancerCoordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stageFrequent disruption of chromodomain helicase DNA-binding protein 8 (CHD8) and functionally associated chromatin regulators in prostate cancerExpression of the CTCFL Gene during Mouse Embryogenesis Causes Growth Retardation, Postnatal Lethality, and Dysregulation of the Transforming Growth Factor β Pathway.Expression of the epigenetic factor BORIS (CTCFL) in the human genomeComparative analyses of CTCF and BORIS occupancies uncover two distinct classes of CTCF binding genomic regions.The significance of epigenetic alterations in lung carcinogenesis.BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer.Genome-Wide Detection of Gene Coexpression Domains Showing Linkage to Regions Enriched with Polymorphic Retrotransposons in Recombinant Inbred Mouse Strains.Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.Testis-specific transcriptional regulators selectively occupy BORIS-bound CTCF target regions in mouse male germ cells.Expression analysis of BORIS during pluripotent, differentiated, cancerous, and non-cancerous cell states.Expression of the cancer-testis antigen BORIS correlates with prostate cancer.The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells.The male germ cell gene regulator CTCFL is functionally different from CTCF and binds CTCF-like consensus sites in a nucleosome composition-dependent manner.The downregulation of putative anticancer target BORIS/CTCFL in an addicted myeloid cancer cell line modulates the expression of multiple protein coding and ncRNA genes.Selective inhibition of CTCF binding by iAs directs TET-mediated reprogramming of 5-hydroxymethylation patterns in iAs-transformed cells.Possible prognostic value of BORIS transcript variants ratio in laryngeal squamous cell carcinomas - a pilot study.Increased expression of brother of the regulator of imprinted sites in peripheral blood neutrophils is associated with both benign and malignant breast lesions.BORIS: a key regulator of cancer stemness
P2860
Q27300849-7EEC4912-FE6B-4135-BDF0-6DB28F047F46Q27331401-6CDE48D7-69D4-4CD2-B503-638AC581BFAAQ28546641-888ABB29-6ECE-424B-ACBF-0EC1CC0394B8Q28727517-6E8252D9-F9AD-403E-ACD7-B0842C7EB6C1Q33572253-8D3D496E-CE85-4CA1-8371-D26818A13B5DQ34287519-005C1C3C-96DB-4C30-8845-34F6D257A8C3Q34434924-30AA1AFC-6522-4469-A830-F07A1C0D1238Q34502974-BB1A8DC0-6297-410B-903C-0622857572F8Q34503710-2BBD69CA-BFB7-45EB-8F99-F541E313D27FQ34810674-66DBD470-0FFD-4D03-ADA2-50CB4D3035BEQ35022469-C695C5C3-E23E-4DA2-9355-433373AA3F10Q35690067-8B5B58D3-AF97-4474-8278-4DA50280C821Q35690493-CCDC86B7-F438-408F-8D1E-21E6895954E5Q36034801-3D83F222-9CE6-4A67-B806-F063898F7AA0Q36457427-D13C8876-7B5D-46B1-94EC-0157E498AD3CQ36574436-3E9346AF-A16F-476E-A192-6DA82549374EQ36744909-CBA3B4E3-8D8B-457E-A927-B306E53464FAQ36998205-54E34A0E-EC16-45F5-A1D7-9A8F6A62641EQ37618285-51AB8640-378A-4262-AB44-C58D51A47A55Q38306384-A41963B8-FFD0-45DD-AEA1-A25B0EA7457DQ39079438-9495ABBF-C561-4DD3-9E3E-7629C53BA116Q39172013-4319FF56-1ED6-486E-B926-3E6AAF5B9240Q42121580-953D848C-0A05-4E41-8DEA-9EF9461CE844Q42778353-354F2622-0800-48D0-90DB-9019B26FB100Q47116981-A0675178-D919-4DAC-B2FD-AE71AC7E5245Q51109227-CE2B9907-CEA7-47AE-BE81-D280A282CAD1Q53762384-FEE6B208-B4BA-42D9-9387-32EE3F69FDB1Q57482782-D4F65FCA-BFFA-40AD-A58D-9A5D80CCA22F
P2860
The structural complexity of the human BORIS gene in gametogenesis and cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The structural complexity of the human BORIS gene in gametogenesis and cancer.
@ast
The structural complexity of the human BORIS gene in gametogenesis and cancer.
@en
type
label
The structural complexity of the human BORIS gene in gametogenesis and cancer.
@ast
The structural complexity of the human BORIS gene in gametogenesis and cancer.
@en
prefLabel
The structural complexity of the human BORIS gene in gametogenesis and cancer.
@ast
The structural complexity of the human BORIS gene in gametogenesis and cancer.
@en
P2093
P2860
P50
P1433
P1476
The structural complexity of the human BORIS gene in gametogenesis and cancer.
@en
P2093
Alexander A Vostrov
Dmitri Loukinov
Elena M Pugacheva
Eugene Barsov
Jeongheon Yoon
Natsuki Kosaka-Suzuki
Teruhiko Suzuki
P2860
P304
P356
10.1371/JOURNAL.PONE.0013872
P407
P577
2010-11-08T00:00:00Z